Lab News

Congratulations!

To Kyle for publishing, Disassociating drug active ingredients from inactive: ketamine-like synaptic effects of a ketamine excipient, in Neuropsychopharmacology 2023.

To Evan for publishing , Relative to females, male rats are more willing to forego obtaining sucrose reward in order to prevent harm to their cage mate, in Psychopharmacology.

The Gould Lab welcomes new lab members, Phylicia and Ryan .

Dr. Gould is invited to speak for the scientific session at the 61st Annual Meeting of the Psychiatric Research Society in Park City, Utah.

Evan publishes a perspective article, Possible psychedelic therapeutic mechanism, in Science.

Kyle presents his research at the 61st Annual ACNP Meeting in Phoenix, Arizona. 

Sarah is awared a 2022 Brain and Behavior Research Foundation Young Investigator Grant to study the role of T cells in postnatal BNST development and social behavior.

Sarah receives the 2022 Betty Huse Award from the Department of Psychiatry at University of Maryland School of Medicine as the co-investigator with Dr. Leon Brown as the principal investigator to conduct "an anatomical investigation of the lateral habenula and its role in ADHD". 

The Gould Lab welcomes new lab members, Abagail and Musa .

Morris presents his research at Immunology2022 conference in Portland, Oregon. 

Lace ​is awarded the 2022 Society for Biological Psychiatry Predoctoral Scholars Travel Fellowship Award.

Poly ​presents her research at 60th Annual American College of Neuropsychopharmacology Meeting in San Juan, Puerto Rico. 

Morris ​presents his research at Silvio O. Conte Center Virtual Research Symposium. 

Poly ​is invited to present at Johns Hopkins Department of Psychiatry and Behavioral Sciences Research Conference. 

Evan receives a fellowship through the Maryland Psychiatric Research Center NIH/NIMH T32 grant. 

Lace is among only 25 neuroscientists in the nation who were selected for the prestigious NIH Outstanding Scholars in Neuroscience Award Program.

Poly is awarded the prestigious Marie Skłodowska-Curie Fellowship to investigate "Reciprocal interactions between hypogonadism and epigenetic modifications: A path for the development of personalized treatments for depression".

Dr. Gould receives promotion to full Professor of the Departments of Psychiatry, Pharmacology, and Anatomy and Neurobiology.

News Features

- Dr. Gould was quoted in a December, 2023 Healthline News article:  Deepak Chopra Shares How Psychedelics May Help Treat Depression, PTSD, and More .

- Dr. Gould was featured in a faculty spotlight in UMB's Programs in Neuroscience (PIN) 2023 Brainstorm Newsletter. It includes a detailed Q&A where you can learn more about the man behind the helm!

- Dr. Gould discusses a previous study linking allergen exposures to altered cytokine levels as well as anxiety-like behaviors in rodents in The Connection between Seasonal Allergies and Mental Health by Christina Caron in The New York Times

- Dr. Gould comments on the potential of using ketamine as a basis to develop other new molecules with antidepressant properties but not the adverse side effects in Ketamine: Could this anesthetic be the key to treating neurological disorders? by Adam Zamecnik in Pharmaceutical Technology.

- Dr. Gould talks about ketamine's off-label use and how it works to relieve symptoms of depression in a news article for Verywell Mind titled One Woman's Journey and Success With Ketamine Therapy written by Cathy Cassata

- Dr. Gould is quoted in Psychedelic drugs take on depression by Cassandra Willyard in Nature Outlook.

- Lace is interviewed by Adam Levy on the Knowable Podcast, talking about  How antidepressants changed ideas about depression .
 
- Dr. Gould talks about ketamine's mechanisms of actions and down stream effectors as well as ketamine metabolite, (2R, 6R)-HNK's invovlement in antidepressant effects in Are Psychedelics the Next Big Treatment for Depression? by Hannah Thomasy in The Daily Beast.